M. Mano et al., Prostaglandin E-2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor, CALCIF TIS, 67(1), 2000, pp. 85-92
Prostaglandins (PGs) are well known to be important local factors in regula
ting bone formation and resorption. PGE(2) is a potent stimulator of bone r
esorption because of enhancing osteoclast formation by its indirect action
through stromal cells. However, the direct action of PGE(2) on functionally
mature osteoclasts is still controversial. In this study using highly puri
fied rabbit mature osteoclasts, we examined the direct effect of PGE(2) on
osteoclastic bone-resorbing activity and its mechanism. PGE(2) inhibited re
sorption pit formation on a dentine slice by the purified osteoclasts in a
dose- and time-dependent manner. The inhibitory effect appeared as early as
4 hours after the PGE(2) addition. Forskolin and 12-0-tetradecanoyl phorbo
l-13-acetate (TPA), respective activators of adenylate cyclase and protein
kinase C, also decreased the osteoclastic bone-resorbing activity. PGE(2) i
ncreased the content of intracellular cAMP in a dose range effective for th
e inhibition of bone resorption, whereas the prostanoid did not alter the i
ntracellular level of inositol triphosphate. The inhibition of osteoclastic
bone resorption by PGE(2) was amplified and diminished by a cAMP phosphodi
esterase inhibitor (isobutyl methylxanthine) and a protein kinase A inhibit
or (Rp-cAMP), respectively. Of four different subtypes of PGE(2) receptors
(EPs), EP4 mRNA was predominantly expressed in isolated osteoclasts, wherea
s the other types of EP mRNA were detected in only small amounts. These res
ults suggest that the PGE(2) inhibitory effect was mediated by an adenylate
cyclase system coupled with EP4, This possible association of PGE(2) with
EP4 in mature osteoclasts was supported by the finding that a specific agon
ist of EP4 (AE-604) inhibited the bone-resorbing activity and elevated the
intracellular cAMP content. However, butaprost, a selective EP2 agonist, al
so mimicked the PGE(2) effects on isolated osteoclasts although EP2 mRNA ex
pression was minimal. In conclusion, PGE(2) directly inhibits bone-resorbin
g activity of functionally mature osteoclasts by activation of the adenylat
e cyclase system, perhaps mainly through EP4.